Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel

Angiogenesis is critical to the growth of tumors. Vascularization-targeting agents, with or without cytotoxic drugs, are widely used for the treatment of several solid tumors including esophagogastric adenocarcinoma. However, little is known about the systemic effects of anti-angiogenic therapies an...

Descripción completa

Detalles Bibliográficos
Autores principales: Steins, Anne, Ebbing, Eva A., Pistorius, Marcel C. M., Waasdorp, Cynthia, Krishnadath, Kausilia K., Medema, Jan Paul, Wilmink, Johanna W., Mathôt, Ron A. A., Bijlsma, Maarten F., van Laarhoven, Hanneke W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241153/
https://www.ncbi.nlm.nih.gov/pubmed/29172757
http://dx.doi.org/10.1080/10717544.2017.1406559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241153/
https://www.ncbi.nlm.nih.gov/pubmed/29172757
http://dx.doi.org/10.1080/10717544.2017.1406559

Ejemplares similares